Yaroslau Compta
Servicio de Neurología NeurólogoGrupo de investigación
Sobre mí
Dr. Yaroslau Compta (MD; PhD) got his MD at the School of Medicine of the University of Barcelona between 1995 and 2001, and completed his specialized training in Neurology between 2002 and 2006 at Hospital Clínic de Barcelona. He obtained his PhD at the University of Barcelona on clinico-pathological and cerebrospinal fluid and imaging biomarker correlates of dementia in Parkinson's disease in 2013 with commendations (thesis supervisor: Dr MJ Marti), with part of the studies having been conducted during his predoctoral stay at the Queen's Square Brain Bank for Neurodegenerative Disorders (London, UK, spring 2006 and Sept 2008 - March 2009), under the supervision of Prof. AJ Lees and Prof. T. Revesz. Since April 2009 he has been a staff neurologist at the Neurology Service of Hospital Clín
Publicaciones destacadas
-
Association of PSP phenotypes with survival: A brain-bank study
Autores:Referencia: Parkinsonism & Related Disorders 2021. -
Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction
Autores:Referencia: Journal Of Parkinsons Disease 2021. -
Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study
Autores:Referencia: Parkinsonism & Related Disorders 2020. -
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Autores:Referencia: Movement Disorders 2017. -
Correlates of cerebrospinal fluid levels of oligomeric-and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease
Autores:Referencia: Journal Of Neurology 2015. -
Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
Autores:Referencia: Parkinsonism & Related Disorders 2013. -
Lewy- and Alzheimer-type pathologies in Parkinson''s disease dementia: which is more important?
Autores:Referencia: Brain 2011. -
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Autores:Referencia: Brain 2009. -
Cerebrospinal Tau, Phospho-Tau, and Beta-Amyloid and Neuropsychological Functions in Parkinson's Disease
Autores:Referencia: Movement Disorders 2009.
Proyectos destacados
-
Clinical Cohort study with biomarkers study of prediagnostic cases and health education program in established disease..
Investigador/a principal: Yaroslau Compta HirnyiFinanciador: La MARATO - TV3Código: 202009-10_PSP REGISTRYDuración: 12/03/2020 - 29/03/2024 -
Amplificación de autoagregación de alfa-sinucleína y 4R-tau en tejido cerebral y líquido cerebrospinal mediante RTQuIC como biomarcador diferencial de parkinsonismos degenerativos.
Investigador/a principal: Yaroslau Compta HirnyiFinanciador: ISCIIIDuración: 01/01/2018 - 31/10/2021 -
FAIR-PARK-II A multicentre, parallel group, randomized, placebo-controlled trial of deferiprone (DFP) 15 mg/kg BID
Investigador/a principal: Yaroslau Compta HirnyiFinanciador: H2020, European ComissionDuración: 05/01/2016 - 01/12/2021